Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
Garsen M, Buijsers B, Sol M, Gockeln L, Sonneveld R, van Kuppevelt TH, de Graaf M, van den Born J, Kamps JAAM, van Raalte DH, van der Meer RW, Lamb HJ, Hillebrands JL, Rabelink TJ, Maciej-Hulme ML, Krenning G, Nijenhuis T, van der Vlag J. Garsen M, et al. Among authors: van den born j, van kuppevelt th, van der meer rw, van der vlag j, van raalte dh. EBioMedicine. 2023 Apr;90:104506. doi: 10.1016/j.ebiom.2023.104506. Epub 2023 Mar 6. EBioMedicine. 2023. PMID: 36889064 Free PMC article.
Age Ain't Nothing But a Number . . . or Is It?
Redondo MJ, van Raalte DH. Redondo MJ, et al. Among authors: van raalte dh. Diabetes Care. 2023 Jun 1;46(6):1135-1136. doi: 10.2337/dci23-0013. Diabetes Care. 2023. PMID: 37220267 Free PMC article. No abstract available.
Diabetes care in older people: a call for action.
Muskiet MHA, Elders PJM, van Raalte DH. Muskiet MHA, et al. Among authors: van raalte dh. Lancet Healthy Longev. 2023 Dec;4(12):e657-e659. doi: 10.1016/S2666-7568(23)00234-9. Lancet Healthy Longev. 2023. PMID: 38042157 Free article. No abstract available.
Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus.
Tonneijck L, Muskiet MHA, Blijdorp CJ, Smits MM, Twisk JW, Kramer MHH, Danser AHJ, Diamant M, Joles JA, Hoorn EJ, van Raalte DH. Tonneijck L, et al. Among authors: van raalte dh. Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F231-F240. doi: 10.1152/ajprenal.00432.2018. Epub 2018 Oct 24. Am J Physiol Renal Physiol. 2019. PMID: 30353743 Free article. Clinical Trial.
Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial.
Smits MM, Tonneijck L, Muskiet MH, Kramer MH, Diamant M, Pieters-van den Bos IC, van Raalte DH, Cahen DL. Smits MM, et al. Among authors: van raalte dh. Diabetes Obes Metab. 2016 Mar;18(3):281-8. doi: 10.1111/dom.12612. Epub 2016 Jan 13. Diabetes Obes Metab. 2016. PMID: 26640129 Clinical Trial.
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ, Diamant M, Joles JA, van Raalte DH. Tonneijck L, et al. Among authors: van raalte dh. Diabetologia. 2016 Jul;59(7):1412-1421. doi: 10.1007/s00125-016-3938-z. Epub 2016 Apr 1. Diabetologia. 2016. PMID: 27038451 Free PMC article. Clinical Trial.
Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Tonneijck L, Smits MM, Muskiet MH, Hoekstra T, Kramer MH, Danser AH, Ter Wee PM, Diamant M, Joles JA, van Raalte DH. Tonneijck L, et al. Among authors: van raalte dh. Diabetes Care. 2016 Nov;39(11):2042-2050. doi: 10.2337/dc16-1371. Epub 2016 Sep 1. Diabetes Care. 2016. PMID: 27585605 Clinical Trial.
211 results